Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123080562 | 12308056 | 2 | F | 2015 | 20160623 | 20160426 | 20160705 | EXP | US-SA-2016SA081039 | AVENTIS | 73.00 | YR | E | F | Y | 0.00000 | 20160705 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123080562 | 12308056 | 1 | PS | LANTUS SOLOSTAR | INSULIN GLARGINE | 1 | Unknown | DOSE:40 UNIT(S) | 5F2510A | 21081 | INJECTION | QD | |||||||
| 123080562 | 12308056 | 2 | SS | LANTUS SOLOSTAR | INSULIN GLARGINE | 1 | Unknown | DOSE:40 UNIT(S) | 5F2531A | 21081 | INJECTION | QD | |||||||
| 123080562 | 12308056 | 3 | SS | LANTUS SOLOSTAR | INSULIN GLARGINE | 1 | Unknown | DOSE:40 UNIT(S) | 5F2510A | 21081 | INJECTION | QD | |||||||
| 123080562 | 12308056 | 4 | SS | LANTUS SOLOSTAR | INSULIN GLARGINE | 1 | Unknown | DOSE:40 UNIT(S) | 5F2531A | 21081 | INJECTION | QD | |||||||
| 123080562 | 12308056 | 5 | C | SOLOSTAR | DEVICE | 1 | 0 | QD | |||||||||||
| 123080562 | 12308056 | 6 | C | SOLOSTAR | DEVICE | 1 | 0 | QD | |||||||||||
| 123080562 | 12308056 | 7 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
| 123080562 | 12308056 | 8 | C | AVAPRO | IRBESARTAN | 1 | 0 | ||||||||||||
| 123080562 | 12308056 | 9 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 123080562 | 12308056 | 10 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
| 123080562 | 12308056 | 11 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123080562 | 12308056 | 1 | Type 2 diabetes mellitus |
| 123080562 | 12308056 | 2 | Type 2 diabetes mellitus |
| 123080562 | 12308056 | 3 | Type 2 diabetes mellitus |
| 123080562 | 12308056 | 4 | Type 2 diabetes mellitus |
| 123080562 | 12308056 | 7 | Blood pressure measurement |
| 123080562 | 12308056 | 8 | Blood pressure measurement |
| 123080562 | 12308056 | 9 | Dyspepsia |
| 123080562 | 12308056 | 10 | Blood pressure measurement |
| 123080562 | 12308056 | 11 | Cerebrovascular accident |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123080562 | 12308056 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123080562 | 12308056 | Cataract | |
| 123080562 | 12308056 | Eye disorder | |
| 123080562 | 12308056 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123080562 | 12308056 | 1 | 20160404 | 20160405 | 0 | |
| 123080562 | 12308056 | 2 | 20160404 | 20160405 | 0 | |
| 123080562 | 12308056 | 3 | 2011 | 0 | ||
| 123080562 | 12308056 | 4 | 2011 | 0 | ||
| 123080562 | 12308056 | 5 | 20160404 | 20160405 | 0 | |
| 123080562 | 12308056 | 6 | 2011 | 0 | ||
| 123080562 | 12308056 | 7 | 2010 | 0 | ||
| 123080562 | 12308056 | 8 | 2010 | 0 | ||
| 123080562 | 12308056 | 9 | 2010 | 0 | ||
| 123080562 | 12308056 | 10 | 20160225 | 0 | ||
| 123080562 | 12308056 | 11 | 2016 | 0 |